Description: China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Home Page: www.shineway.com
No. 168, Shiluan Street
Shijiazhuang,
051430
China
Phone:
86 31 1880 30066
Officers
| Name | Title |
|---|---|
| Mr. Zhenjiang Li | Co-Founder & Executive Chairman |
| Ms. Yunxia Xin | Co-Founder & Executive Director |
| Mr. Huimin Li | Executive Director |
| Mr. Bun Ching Lee | Financial Controller & Company Secretary |
| Mr. King Kuen Hung AICPA, HKICPA, MBA | Director of Investor Relation |
| Mr. Yudong Zhang | General Manager of Sales & Marketing |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 4.781 |
| Price-to-Book MRQ: | 0.7652 |
| Price-to-Sales TTM: | 0.2016 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3232 |